Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012 (2012), Article ID 158075, 5 pages
http://dx.doi.org/10.1100/2012/158075
Research Article

Predictors of Acquired Perforating Dermatosis in Uremic Patients on Hemodialysis: A Case-Control Study

1Department of Nephrology, Chang Gung Memorial Hospital, 5 Fu-Shin Street, Kwei-Shan, Taoyuan 333, Taiwan
2College of Medicine, Chang Gung University, Taoyuan 333, Taiwan
3Department of Hepatogastroenterology and Liver Research Unit, Chang Gung Memorial Hospital, Keelung 204, Taiwan
4Department of Pathology, Chang Gung Memorial Hospital, Linkou 333, Taiwan
5Department of Dermatology, Chang Gung Memorial Hospital, Linkou 333, Taiwan

Received 22 October 2012; Accepted 3 December 2012

Academic Editors: E. Haneke, A. Ishida-Yamamoto, K. Krasagakis, T. L. Meinking, and U. Wollina

Copyright © 2012 Cheng-Hao Weng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Kreuter and T. Gambichler, “Acquired reactive perforating collagenosis,” Canadian Medical Association Journal, vol. 182, no. 4, p. E184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. C. B. Lynde and M. D. Pratt, “Acquired perforating dermatosis: association with diabetes and renal failure,” Canadian Medical Association Journal, vol. 181, no. 9, p. 615, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. D. L. Maurice, “Acquired perforating dermatosis in renal patients,” Nephrology Dialysis Transplantation, vol. 12, no. 12, pp. 2774–2775, 1997. View at Google Scholar · View at Scopus
  4. D. L. Andress, D. B. Endres, and N. A. Maloney, “Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy,” Journal of Clinical Endocrinology and Metabolism, vol. 63, no. 5, pp. 1163–1169, 1986. View at Google Scholar · View at Scopus
  5. “K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease,” American Journal of Kidney Diseases, vol. 42, pp. S1–S201, 2003.
  6. K. Kalantar-Zadeh, N. Kuwae, D. L. Regidor et al., “Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients,” Kidney International, vol. 70, no. 4, pp. 771–780, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. G. A. Block, P. S. Klassen, J. M. Lazarus, N. Ofsthun, E. G. Lowrie, and G. M. Chertow, “Mineral metabolism, mortality, and morbidity in maintenance hemodialysis,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 2208–2218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. S. G. Rostand and T. B. Drüeke, “Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure,” Kidney International, vol. 56, no. 2, pp. 383–392, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. K. D. Schlüter and H. M. Piper, “Cardiovascular actions of parathyroid hormone and parathyroid hormone- related peptide,” Cardiovascular Research, vol. 37, no. 1, pp. 34–41, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Myetes, E. Bogin, and A. Ma, “Effect of parathyroid hormone on erythropoiesis,” Journal of Clinical Investigation, vol. 67, no. 5, pp. 1263–1269, 1981. View at Google Scholar · View at Scopus
  11. S. G. Massry, J. M. Alexiewicz, Z. Gaciong, and M. Klinger, “Secondary hyperparathyroidism and the immune system in chronic renal failure,” Seminars in Nephrology, vol. 11, no. 2, pp. 186–201, 1991. View at Google Scholar · View at Scopus
  12. R. Dukkipati, C. P. Kovesdy, S. Colman et al., “Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients,” Journal of Renal Nutrition, vol. 20, no. 4, pp. 243–254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. C. A. Morton, I. S. Henderson, M. C. Jones, and J. G. Lowe, “Acquired perforating dermatosis in a British dialysis population,” British Journal of Dermatology, vol. 135, no. 5, pp. 671–677, 1996. View at Google Scholar · View at Scopus
  14. S. L. Cheng, J. S. Shao, L. R. Halstead, K. Distelhorst, O. Sierra, and D. A. Towler, “Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/β-catenin signaling and aortic fibrosis in diabetic arteriosclerosis,” Circulation Research, vol. 107, no. 2, pp. 271–282, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Inaba, S. Okuno, K. Nagasue et al., “Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patients,” American Journal of Kidney Diseases, vol. 38, no. 4, pp. S139–S142, 2001. View at Google Scholar · View at Scopus
  16. M. Nagano, K. Fukami, S. I. Yamagishi et al., “Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients,” Nephrology, vol. 16, no. 3, pp. 299–303, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Fujimoto, T. Kobayashi, N. Fujimoto, M. Akiyama, S. Tajima, and R. Nagai, “AGE-modified collagens i and III induce keratinocyte terminal differentiation through AGE receptor CD36: Epidermal-dermal interaction in acquired perforating dermatosis,” Journal of Investigative Dermatology, vol. 130, no. 2, pp. 405–414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Abdellaoui and H. Al-Khaffaf, “C-reactive protein (CRP) as a marker in peripheral vascular disease,” European Journal of Vascular and Endovascular Surgery, vol. 34, no. 1, pp. 18–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. E. G. Lowrie and N. L. Lew, “Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities,” American Journal of Kidney Diseases, vol. 15, no. 5, pp. 458–482, 1990. View at Google Scholar · View at Scopus
  20. W. F. Owen, N. L. Lew, Y. Liu, E. G. Lowrie, and J. M. Lazarus, “The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis,” The New England Journal of Medicine, vol. 329, no. 14, pp. 1001–1006, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. G. A. Kaysen, J. A. Dubin, H. G. Müller, L. Rosales, N. W. Levin, and W. E. Mitch, “Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients,” Kidney International, vol. 65, no. 4, pp. 1408–1415, 2004. View at Publisher · View at Google Scholar · View at Scopus